TODD ROSENGART to Treatment Outcome
This is a "connection" page, showing publications TODD ROSENGART has written about Treatment Outcome.
Connection Strength
0.648
-
Commentary: NIH Funding Remains Vital for Cardiothoracic Surgeon Scientists. Semin Thorac Cardiovasc Surg. 2021; 33(4):1057-1058.
Score: 0.056
-
Outcomes of 3309 thoracoabdominal aortic aneurysm repairs. J Thorac Cardiovasc Surg. 2016 May; 151(5):1323-37.
Score: 0.039
-
Informed consent for cardiac procedures: deficiencies in patient comprehension with current methods. Ann Thorac Surg. 2014 May; 97(5):1505-11; discussion 1511-2.
Score: 0.034
-
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration. J Thorac Cardiovasc Surg. 2013 Nov; 146(5):1259-1266, 1266.e1; discussion 1266.
Score: 0.033
-
In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc. 2012 Dec; 1(6):e005652.
Score: 0.032
-
Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts. J Thorac Cardiovasc Surg. 2007 Feb; 133(2):478-484.e2.
Score: 0.021
-
Low socioeconomic status adversely influences outcomes after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2025 11; 170(5):1480-1490.e5.
Score: 0.018
-
Minimally Invasive Mitral Valve Surgery Using a Cold Fibrillatory Cardiac Arrest Technique in Patients With Prior Cardiac Surgery. Tex Heart Inst J. 2024 07 19; 51(2).
Score: 0.018
-
Angiogenic Gene Therapy for Refractory Angina: Results of the EXACT Phase 2 Trial. Circ Cardiovasc Interv. 2024 05; 17(5):e014054.
Score: 0.017
-
Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg. 2004 Apr; 127(4):1041-9; discussion 1049-51.
Score: 0.017
-
Therapeutic angiogenesis: a biologic bypass. Cardiology. 2004; 101(1-3):131-43.
Score: 0.017
-
EXACT Trial: Results of the Phase 1 Dose-Escalation Study. Circ Cardiovasc Interv. 2023 08; 16(8):e012997.
Score: 0.016
-
Readmissions After Surgical Aortic Valve Replacement: Influence of Prosthesis Type. J Surg Res. 2023 07; 287:124-133.
Score: 0.016
-
Readmission After Bioprosthetic vs Mechanical Mitral Valve Replacement in the United States. Ann Thorac Surg. 2024 01; 117(1):113-118.
Score: 0.015
-
Racial/ethnic differences persist in treatment choice and outcomes in isolated intervention for coronary artery disease. J Thorac Cardiovasc Surg. 2023 10; 166(4):1087-1096.e5.
Score: 0.015
-
Open heart surgery in the elderly: results from a consecutive series of 100 patients aged 85 years or older. Am J Med. 2002 Feb 01; 112(2):143-7.
Score: 0.015
-
Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA Tissue. Ann Thorac Surg. 2023 06; 115(6):1429-1436.
Score: 0.015
-
Left Ventricle Mass Regression After Surgical or Transcatheter Aortic Valve Replacement in Veterans. Ann Thorac Surg. 2022 07; 114(1):77-83.
Score: 0.014
-
Epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (The EXACT Trial): Rationale, design, and clinical considerations. Am Heart J. 2021 11; 241:38-49.
Score: 0.014
-
Outcomes of Aortic Valve Replacement for Chronic Aortic Insufficiency: Analysis of the Society of Thoracic Surgeons Database. Ann Thorac Surg. 2022 03; 113(3):763-772.
Score: 0.014
-
Consistent improvements in short- and long-term survival following heart transplantation over the past three decades. Clin Transplant. 2021 04; 35(4):e14241.
Score: 0.014
-
Mid-Term Efficacy of Subxiphoid Versus Transpleural Pericardial Window for Pericardial Effusion. J Surg Res. 2020 08; 252:9-15.
Score: 0.013
-
Heterotopic Cardiac Transplantation: Long-term Results and Fate of the Native?Heart. Ann Thorac Surg. 2020 10; 110(4):1316-1323.
Score: 0.013
-
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999 Aug 03; 100(5):468-74.
Score: 0.012
-
Mitral Valve Repair Rate at a Veterans Affairs Hospital Utilizing a Multidisciplinary Heart Team. Semin Thorac Cardiovasc Surg. 2019; 31(3):434-441.
Score: 0.012
-
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
Score: 0.012
-
Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution. Ann Thorac Surg. 1998 Nov; 66(5):1684-91.
Score: 0.012
-
Effect of concomitant mitral valve procedures for severe mitral regurgitation during left ventricular assist device implantation. J Artif Organs. 2019 Jun; 22(2):91-97.
Score: 0.012
-
Successful Conservative Management of a Large Splenic Abscess Secondary to Infective Endocarditis. Ann Thorac Surg. 2019 04; 107(4):e235-e237.
Score: 0.012
-
Retrograde autologous priming for cardiopulmonary bypass: a safe and effective means of decreasing hemodilution and transfusion requirements. J Thorac Cardiovasc Surg. 1998 Feb; 115(2):426-38; discussion 438-9.
Score: 0.011
-
In elective arch surgery with circulatory arrest, does the arterial cannulation site really matter? A propensity score analysis of right axillary and innominate artery cannulation. J Thorac Cardiovasc Surg. 2018 05; 155(5):1953-1960.e4.
Score: 0.011
-
Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis. Ir J Med Sci. 2018 May; 187(2):369-377.
Score: 0.011
-
The COMMENCE trial: 2-year outcomes with an aortic bioprosthesis with RESILIA tissue. Eur J Cardiothorac Surg. 2017 Sep 01; 52(3):432-439.
Score: 0.011
-
Incidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans. Tex Heart Inst J. 2016 Oct; 43(5):397-403.
Score: 0.010
-
Trends in Robotic-Assisted Coronary Artery Bypass Grafts: A Study of The Society of Thoracic Surgeons Adult Cardiac Surgery Database, 2006 to 2012. Ann Thorac Surg. 2016 Jul; 102(1):140-6.
Score: 0.010
-
Total aortic arch replacement: A comparative study of zone 0 hybrid arch exclusion versus traditional open repair. J Thorac Cardiovasc Surg. 2015 Dec; 150(6):1591-8; discussion 1598-600.
Score: 0.010
-
Reoperations on the total aortic arch in 119 patients: short- and mid-term outcomes, focusing on composite adverse outcomes and survival analysis. J Thorac Cardiovasc Surg. 2014 Dec; 148(6):2967-72.
Score: 0.009
-
Completeness of coronary revascularization and survival: Impact of?age and off-pump surgery. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1307-1315.e1.
Score: 0.008
-
Trends in use of off-pump coronary artery bypass grafting: Results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. J Thorac Cardiovasc Surg. 2014 Sep; 148(3):856-3, 864.e1; discussion 863-4.
Score: 0.008